Cellectis Announces Presentation At The 34th Annual J.P. Morgan Healthcare Conference In San Francisco, January 11 - 14, 2016
NEW YORK--(BUSINESS WIRE)--Regulatory News:
Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Alternext: ALCLS – Nasdaq: CLLS), a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR-T cells (UCART), today announced that it will be presenting at the 34th Annual J.P. Morgan Healthcare Conference.
The Cellectis presentation will take place on Thursday, January 14, 2016, at 10:30AM Pacific Time, followed by a Q&A session at 11:00AM Pacific Time, at the Westin St. Francis Hotel, San Francisco, California.
Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Alternext: ALCLS – Nasdaq: CLLS), a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR-T cells (UCART), today announced that it will be presenting at the 34th Annual J.P. Morgan Healthcare Conference.
The Cellectis presentation will take place on Thursday, January 14, 2016, at 10:30AM Pacific Time, followed by a Q&A session at 11:00AM Pacific Time, at the Westin St. Francis Hotel, San Francisco, California.